Palliative Care and Oncology - Cannabis as Supportive Treatment

6 min read

Palliative Care and Oncology - Cannabis as Supportive Treatment

Cannapio seedsOur own brandBrowse ›Tip for this articleAuto Banana OG Kush - autoflowering seeds 5 pcs Cannapio€19.30Browse ›Tip for this articleAuto Pure Haze - 3pcs Cannapio Autoflowering Seeds€9.20Browse ›
One of the newly researched spheres of potential cannabis use is palliative care

Medicinal cannabis represents a fascinating area of research that has captured the attention of scientists and genetic collectors alike. The most recent studies focus on the therapeutic potential of certain varieties as supporting genetic material in palliative treatments, highlighting the unique cannabinoid profiles that define each strain.

The most studied cannabis genetics in this context present specific properties related to various symptoms. Among the characteristics most valued by researchers, we find varieties known for their profiles:

  • Antiemetic and digestive
  • Relaxing and sedative
  • Analgesic
  • Anxiolytic and mood stabilizer

What is particularly interesting for collectors is that certain genetics combine multiple therapeutic profiles in a single variety, creating exceptional genetic material with complex and balanced chemical compositions.

Pioneering Research in Specialized Genetics

A revolutionary study published in the prestigious "European Journal of Internal Medicine" analyzed the genetic characteristics used by 2,960 Israeli patients during a 6-month observation period. Of the total participants, 1,742 completed the study. The results were extraordinary: "60% of the participants who completed the study reported significant benefits," according to Dr. Victor Novak, lead researcher at the specialized cannabis clinic of Soroka University in Israel.

This type of research provides invaluable data on the most effective genetic characteristics and their unique chemical profiles, crucial information for collectors specialized in varieties with specific properties.

Israel: World Leader in Cannabis Genetics Research

Since 2007, the Israeli Ministry of Health has regulated medicinal cannabis, creating a unique ecosystem for specialized genetics research. A prominent company in this field is "Tikun-Olam" (meaning "to repair the world" in Hebrew), an authorized private organization specializing in the development of medicinal-quality cannabis genetics with unique terpene profiles.

The research team analyzed data from 3,000 patients, examining the characteristics of the genetics used. The most sought-after profiles included varieties known for:

  • Sedative and sleep-inducing properties (78.4%)
  • Analgesic characteristics (77.7%)
  • Antiemetic and appetite-stimulating profiles (48.9%)

It is important to note that of the initial group, 902 participants (24.9%) did not complete the study due to natural circumstances, and 682 (18.8%) discontinued the use of cannabis genetics during the observation period.

The remaining 1,211 participants (60.6%) who completed the study reported:

  • 95% experienced improvements during treatment
  • 3.7% observed no significant changes
  • 0.3% reported negative effects

Integration of Cannabis Genetics in Oncology

Dr. Donald I. Abrams, hematologist-oncologist from San Francisco, advocates for the use of specific cannabis genetics as a complement in palliative treatments. "I have had the opportunity to observe clinically and first-hand how certain cannabis genetics can benefit patients with cancer and related symptoms," explains Abrams. He adds that, compared to cannabis, pharmaceutical opioids can compromise the communication ability of patients in advanced stages.

"Many of my patients have managed to gradually and safely reduce all opioids and analgesics thanks to specific cannabis genetics." - Dr. Donald I. Abrams

Although analgesics and opioids are effective for pain management, their side effects can be counterproductive in comprehensive treatment. A common issue is physical dependence and the patient's inability to manage pain without medication, experiencing withdrawal symptoms when discontinuing treatment.

Synergistic Combinations: Cannabis and Conventional Therapies

Cannabis genetics research offers significant advantages, including the considerably lower toxicity of cannabinoids and the minimal risk of developing physical dependence. A particularly interesting characteristic is the ability of certain genetics to complement opioid therapies.

"Although additional research is required, it appears that cannabinoids may enhance the effects of opioids, allowing for reduced dosages and, consequently, lower toxicity, dependence, and negative side effects. It is crucial to remember that cannabis genetics research in oncology represents an integrative approach, complementing existing treatments."

"Any consideration regarding the use of specific cannabis genetics must be carried out under medical supervision. Abandoning established treatments can be potentially dangerous."

Research continues to reveal the complexities of different cannabis genetics and their unique cannabinoid and terpene profiles. For specialized collectors, these investigations provide valuable information about the chemical and genetic characteristics that define the most interesting varieties from a botanical and research perspective.